WolfgangSingerMD

Neuromuscular Medicine, Neurophysiology

Associate Professor, Neurology, Mayo Medical School

Dr. Singer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Mayo Clinic College of Medicine and Science (Rochester)Residency, Neurology, 2004 - 2007
Mayo Clinic College of Medicine and Science (Rochester)Internship, Internal Medicine, 2003 - 2004
University of Erlangen - Nuremberg Faculty of MedicineClass of 1997

Mesenchymal Stem Cell Therapy in Multiple System Atrophy Start of enrollment: 2012 Oct 01
Active, not recruiting
Phase 1, Phase 2
Data Collection - Of Syncope Tilt Table Testing Study Start of enrollment: 2019 Oct 04
Completed

PubMed

The phenotype of "pure" autonomic failure.
Elizabeth A Coon, Negin Badihian, Stuart J McCarter, David M Sletten, Sarah E Berini
Clinical Autonomic Research. 2025-03-07
Autonomic dysreflexia with relative tachycardia: Potential physiologic pathways for this head scratching clinical finding.
Ryan Solinsky, Wolfgang Singer
PM & R. 2025-01-01
The impact of anti-inflammatory therapy on Parkinson's disease incidence: A retrospective cohort study.
Michele Potashman, Jennifer S Haas, Ambrish Pandit, Dana Stafkey, Vlad Coric
Parkinsonism & Related Disorders. 2025-01-01

Journal Articles

GI Dysfunctions in Diabetic Gastroenteropathy, Their Relationships with Symptoms, and Effects of a GLP-1 Antagonist
Phillip Low, Subhankar Chakraborty, Michael Camilleri, Adil E Bharucha, Magnus Halland, Wolfgang Singer, The Journal of Clinical Endocrinology and Metabolism

Early Orthostatic Hypotension and Orthostatic Intolerance—More Than an Observation or AnnoyanceJuly 24th, 2017
Hold SteadyJuly 5th, 2017

Synucleinopathies – Novel Targets in Early Diagnosis, Pathophysiology, and Therapeutic ApproachMAYO CLINIC ROCHESTER2015–2026
Randomized Double-Blind Placebo-Controlled Adaptive Design Trial of Intrathecally Administered Autologous Mesenchymal Stem Cells in Multiple System AtrophyMAYO CLINIC ROCHESTER2021–2025